Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,632 recruiting studies in this area right now.
By phase
- Not applicable9,799
- Phase 24,458
- Phase 12,742
- Phase 1/Phase 21,690
- Phase 31,400
- Phase 2/Phase 3279
- Phase 4264
Top conditions
- Breast Cancer1,226
- Cancer659
- Prostate Cancer656
- Colorectal Cancer493
- Lung Cancer426
- Ovarian Cancer341
- Multiple Myeloma331
- Gastric Cancer297
- Pancreatic Cancer292
- Acute Myeloid Leukemia290
- Hepatocellular Carcinoma284
- Solid Tumor258
- Advanced Solid Tumor256
- Cervical Cancer232
- Head and Neck Cancer228
- Endometrial Cancer207
- Advanced Solid Tumors193
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University313
- Sun Yat-sen University291
- Memorial Sloan Kettering Cancer Center288
- National Cancer Institute (NCI)284
- Mayo Clinic240
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center148
- AstraZeneca135
- University Health Network, Toronto125
Where studies are running
- California1,431
- Texas641
- Arizona511
- Florida449
- Alabama417
- New York410
- Massachusetts340
- Maryland329
- New Jersey269
- Pennsylvania240
Recruiting studies20,632 total
- NCT03599843Recruiting
Exercise program for cancer survivors in Halifax
This trial tests whether a supervised, gentle exercise program over 12 weeks can help cancer survivors. You may be eligible if you are currently in cancer treatment, just finished within the past 5 years, or still have lingering side effects.
Halifax, Nova ScotiaAges 18 years+ - NCT03606967RecruitingPhase 2
Individualized vaccine added to standard treatment for metastatic triple-negative breast cancer
This Phase 2 trial tests whether adding a personalized cancer vaccine to durvalumab (an immunotherapy), tremelimumab (another immunotherapy), and chemotherapy can improve outcomes for people with metastatic triple-negative breast cancer. It may help your immune system recognize your specific tumor features.
Orange, CaliforniaAges 18 years+ - NCT03603405RecruitingPhase 1/Phase 2
Test vaccine and radiation with chemotherapy for new brain tumor
This trial studies a gene-based treatment (HSV-tk) given with radiation and chemotherapy for people newly diagnosed with glioblastoma or anaplastic astrocytoma. It may help the new brain tumor respond better to standard treatments, though risks and benefits are still being tested.
Houston, TexasAges 18 years+ - NCT03602092Recruiting
GIST patient registry to improve real-world care
This observational study keeps a registry of people diagnosed with gastrointestinal stromal tumor (GIST) to collect real-life information over time. It may help doctors better understand outcomes and care patterns for future patients.
TaipeiAges 20 years+ - NCT03604315RecruitingPhase 1
PET/CT scan testing a new radioactive tracer for tumors
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
Houston, TexasAges 18 years+ - NCT03604627Recruiting
Checking coronary calcium to study late heart blood vessel changes
This study looks at coronary calcium (a signal seen on heart scans) to help measure early or late heart blood-vessel problems in people who had cancer treatment as children or young adults. The goal is to better understand who may be at higher risk years later, especially after radiation or certain chemotherapy.
Villejuif, Val De MarneAges 18 years+ - NCT03605771Recruiting
Observes people with advanced melanoma in Spain since 2018
This observational study collects information about people with advanced (stage III/IV) melanoma, including cases that are metastatic or cannot be removed by surgery. It may help improve understanding of how melanoma behaves and how it’s being treated across Spain.
Alcoy, AlicanteAges 18 years+ - NCT03609580RecruitingPhase 1/Phase 2
Testing Flomax to prevent urine retention after chest surgery
This study looks at whether starting Flomax around the time of thoracic (chest) surgery can help prevent a painful problem called urinary retention (not being able to pee after surgery). You might benefit if you’re at risk of not urinating after your operation and can safely take Flomax.
Hackensack, New JerseyAges 50 years+ - NCT03608631RecruitingPhase 1/Phase 2
Exosome treatment for KRAS-mutated metastatic pancreatic cancer
This Phase 1/2 study tests an investigational treatment made from “exosomes” for people with metastatic pancreatic cancer that has a specific KRAS mutation (KRAS G12D). It aims to see if this treatment can control the cancer and is safe for patients whose cancer has grown or stayed the same after prior chemotherapy.
Houston, TexasAges 18 years+ - NCT03612726Recruiting
Study for people with unresectable liver cancer
This trial looks at overall survival (how long people live) in real-world patients with unresectable liver cancer. It may help researchers understand outcomes outside of tightly controlled studies.
BeijingAges 18 years+ - NCT03616483Recruiting
Indiana Myeloma Registry for blood cancer-related diagnoses
This registry collects information from adults with certain plasma-cell conditions like MGUS, smoldering multiple myeloma, multiple myeloma, plasmacytoma, or primary amyloidosis. It may help researchers learn more about these diseases and improve future care.
Indianapolis, IndianaAges 18 years+ - NCT03617133RecruitingPhase 2
MRI-guided radiation plus chemo for cervical cancer
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
ViennaAges 18–99 - NCT03620786Recruiting
HIFU experience study for treating parts of the prostate
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
Los Angeles, CaliforniaAges 40–85 - NCT03617237Recruiting
Radiation patient registry for cancer and non-cancer cases
This study keeps records to understand outcomes for people who had radiation treatment (or were evaluated for it) since 2000. It may help doctors compare results for different conditions and treatment approaches, including cancer and non-cancer problems.
Dallas, TexasAges 18–99 - NCT03621904Recruiting
Predicting response to hormone treatment in endometrial cancer
This study looks at whether biopsy test results can help predict how well hormone therapy will work for advanced or recurrent endometrial cancer. It may help doctors choose the most effective hormonal treatment sooner.
NijmegenAges 18–110 - NCT03623958Recruiting
Image-guided minimally invasive lung surgery versus standard surgery
This study compares an image-guided version of a minimally invasive lung surgery to the standard approach for removing small lung nodules. It may help doctors improve planning and targeting of the nodule during surgery.
Boston, MassachusettsAges 18 years+ - NCT03622983Recruiting
Biobank study for pelvic cancers and endometriosis samples
This study collects and stores biological samples (like tissue or other lab samples) from people with pelvic gynecologic cancers or endometriosis, and links them with imaging/radiology information. It may help researchers learn more about these conditions and how they behave over time.
CréteilAges 18 years+ - NCT03624244RecruitingPhase 2
Stopping or continuing hormone pill for low-grade uterine cancer
This Phase 2 trial tests whether it is better to stop a hormone tablet (an aromatase inhibitor) versus keep taking it in people with low-grade endometrial stromal sarcoma whose cancer is currently controlled. It may help find the safest way to maintain disease control while avoiding unnecessary treatment if stopping is possible.
BesançonAges 18 years+ - NCT03624712Recruiting
Improve prediction and treatment plans for uterine cancers
This study looks at better ways to predict disease and choose treatment for cancers of the cervix, endometrium (uterine lining), or uterine sarcoma. It may help patients by testing tools and treatment models that could guide care more accurately.
TübingenAges 18 years+ - NCT03629171RecruitingPhase 2
Venetoclax plus chemo to treat certain AML types
This trial tests a combination of venetoclax with liposome chemotherapy (daunorubicin and cytarabine) for adults with acute myeloid leukemia (AML) that is back after treatment or not responding, and for some newly diagnosed cases. It aims to shrink leukemia and help more people achieve remission.
Houston, TexasAges 18 years+ - NCT03630991RecruitingPhase 1
Calcium chelator medicine for AML or MDS during chemotherapy
This Phase 1 study tests whether edetate calcium disodium (also called succimer) can be safely given to people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) while they are on chemotherapy. The goal is to learn the safest dose and whether it has signs of helping the blood cancer respond to treatment.
Houston, TexasAges 1 year+ - NCT03631953RecruitingPhase 1
Test alpelisib plus trametinib for hard-to-treat meningiomas
This Phase 1 trial studies whether combining two targeted medicines—alpelisib and trametinib—can shrink or slow progressive meningiomas that have already been treated with standard surgery and radiation. If you qualify, you may help test a new treatment approach for tumors that keep growing.
MarseilleAges 18 years+ - NCT03632200Recruiting
Nutrition care plan after head and neck cancer surgery
This study tests a structured nutrition care plan for people after head and neck cancer surgery. It may help you maintain weight and nutrition during recovery so you can heal better.
AmiensAges 18–80 - NCT03637569Recruiting
Skinfold fat measurement and survival in certain digestive cancers
This study looks at whether a simple measurement of fat under the skin (taken at the back of the upper arm) relates to how long people live. It includes adults newly diagnosed with pancreatic, bile duct, or gallbladder cancer who are starting treatment.
SeoulAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,632 recruiting oncology studies from the U.S. registry right now, out of 31,414 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.